• No results found

University of Groningen Improving Buruli ulcer control Wadagni, Anita

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Improving Buruli ulcer control Wadagni, Anita"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Improving Buruli ulcer control Wadagni, Anita

DOI:

10.33612/diss.171907958

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2021

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Wadagni, A. (2021). Improving Buruli ulcer control: steps towards decentralized care. University of Groningen. https://doi.org/10.33612/diss.171907958

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

STATEMENTS – STELLINGEN 1. Epidemiological surveillance is the mother of prevention for any disease control program. (this thesis). 2. Decentralization of care for patients with Buruli ulcer is necessary to improve disease outcome in West African countries like Benin (this thesis). 3. In a setting with limited resources, less surgery in the management of Buruli ulcer is better, in terms of time to healing, residual sequelae, and surely, costs (this thesis). 4. POC diagnostic testing for Buruli ulcer is feasible. Mycolactone shows us the road (this thesis). 5. Reducing surgical interventions will encourage patients with Buruli to present earlier to the health system, thereby improving outcome. 6. Improving wound care for Buruli ulcer provides benefit beyond patients with Buruli ulcer. 7. Quality is based on standardization, which itself is inferred from the number of experiences. 8. Cleanliness is the key to health (African quote) 9. Deny, but if you see, believe (African Quote) 10. "If you want to know the truth, listen to the fools" (African proverb). 11. Horns don't grow before the head (African quote).

Referenties

GERELATEERDE DOCUMENTEN

Following on from reports that avermectins have activity against Mycobacterium tuberculosis, we tested the in-vitro efficacy of ivermectin and moxidectin on M.. We observed

Accumulation observed as increasing trough concentrations after several days of IVM administration (FIG 1C) as well as the previously reported lipophilicity and accumulation

Figure 1: Median of footpad swelling grade of infected mouse footpads in response to treatment with high-dose rifamycins and clarithromycin.. Treatment was initiated 6 weeks

In this experiment, we compared the efficacy of these oxazolidinones, including a reduced dose of LZD, in combination with RIF to that of standard-of-care regimens based on their

ulcerans BALB/c mouse model that yielded high- dose rifampin as high-potential candidate regimen for further evaluation of future highly active, short-course regimen to treat BU,

Three research items should to be addressed concerning BU therapy: a) the dosing and pharmacokinetics of the current RIF+CLR regimen should be further explored and optimized, b)

I would also like to thank all my other teachers, mentors, colleagues and peers in medical school and science that I have met along the way I would like to especially acknowledge the

Improving antimicrobial therapy for Buruli ulcer Omansen, Till Frederik.. IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite